αααααβααΎαNEO β’ BMV
add
NeoGenomics, Inc.
200.00$
4 ααααααΆ, 2:23:13 PM ααααβααα -6 · MXN · BMV · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
MXααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
200.00$
α
ααααααα½αααααΆαα
α»αααααα
200.00$ - 340.00$
ααΎαβαα»αβααΈααααΆα
971.64Β ααΆα USD
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(USD) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 168.04Β ααΆα | 7.55% |
α
αααΆαααααα·ααααα·ααΆα | 101.07Β ααΆα | 7.94% |
α
αααΌααα»ααα | -25.92Β ααΆα | 4.21% |
ααααΆααα
αααααα»ααα | -15.43 | 10.91% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.00 | 100.00% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -10.10Β ααΆα | -1.97% |
α’ααααΆαααααααααΆαααααα·αααααΆα | -1.04% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(USD) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 358.08Β ααΆα | -6.95% |
ααααααααα»α | 1.60Β αααΈααΆα | -2.37% |
ααΆαααα½ααα»αααααΌαααα»α | 713.16Β ααΆα | -0.53% |
ααΌαβααααα»α | 888.27Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 128.69Β ααΆα | β |
ααααααααααΉαααααα
| 28.90 | β |
ααα
ααααααΎαααααα | -4.29% | β |
ααα
ααααααΎααΎααα»α | -4.64% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(USD) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | -25.92Β ααΆα | 4.21% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -25.33Β ααΆα | 2.27% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 3.56Β ααΆα | -75.49% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 949.00Β ααΆαα | 16.30% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -20.82Β ααΆα | -96.88% |
ααα αΌαααΆα
αααααΆααααααα | -21.96Β ααΆα | 6.19% |
α’αααΈ
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
ααΆααααααΎαα‘αΎα
2002
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
2,200